Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063255 · ClinicalTrials.gov registry record · Phase 4
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade
A Phase 4 study of Cancer of Bladder, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03063255 is a Phase 4 study of Cancer of Bladder that has completed, run by University of Florida. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03063255, a Phase 4 study of Cancer of Bladder, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.
Conditions Studied
Interventions
- DRUG Obturator block
- DRUG Neuromuscular block
Study Locations (1)
Florida
- Malcom Randall VA Medical Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2019-09-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063255
The ClinicalTrials.gov registry entry for NCT03063255 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer of Bladder appearing as the primary indexed condition, and to 2 interventions - of which Obturator block is the first listed.
NCT03063255 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03063255 about?
NCT03063255 is a clinical study titled "Comparison of Obturator Nerve Blockade and Neuromuscular Blockade". Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex durin...
What is the current status of trial NCT03063255?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2017-04-25. Estimated completion is 2019-09-19.
What conditions does trial NCT03063255 study?
This clinical trial studies the following conditions: Cancer of Bladder.
What interventions are being tested in trial NCT03063255?
The interventions under investigation include: Obturator block (DRUG), Neuromuscular block (DRUG).
Who is sponsoring clinical trial NCT03063255?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03063255 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.